A 265-Nanometer High-Power Deep-UV Light-Emitting Diode Rapidly Inactivates SARS-CoV-2 Aerosols.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
27 04 2022
Historique:
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 30 4 2022
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19) is an acute respiratory infection transmitted by droplets, aerosols, and contact. Controlling the spread of COVID-19 and developing effective decontamination options are urgent issues for the international community. Here, we report the quantitative inactivation of SARS-CoV-2 in liquid and aerosolized samples by a state-of-the-art, high-power, AlGaN-based, single-chip compact deep-UV (DUV) light-emitting diode (LED) that produces a record continuous-wave output power of 500 mW at its peak emission wavelength of 265 nm. Using this DUV-LED, we observed a greater-than-5-log reduction in infectious SARS-CoV-2 in liquid samples within very short irradiation times (<0.4 s). When we quantified the efficacy of the 265-nm DUV-LED in inactivating SARS-CoV-2, we found that DUV-LED inactivation of aerosolized SARS-CoV-2 was approximately nine times greater than that of SARS-CoV-2 suspension. Our data demonstrate that this newly developed, compact, high-power 265-nm DUV-LED irradiation system with remarkably high inactivation efficiency for aerosolized SARS-CoV-2 could be an effective and practical tool for controlling SARS-CoV-2 spread.

Identifiants

pubmed: 35475734
doi: 10.1128/msphere.00941-21
pmc: PMC9044969
doi:

Substances chimiques

Aerosols 0
Suspensions 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0094121

Références

Water Res. 2006 Jan;40(1):3-22
pubmed: 16386286
mSphere. 2020 Oct 21;5(5):
pubmed: 33087517
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Trends Immunol. 2020 Dec;41(12):1100-1115
pubmed: 33132005
Am J Infect Control. 2021 Mar;49(3):299-301
pubmed: 32896604
Emerg Microbes Infect. 2020 Dec;9(1):1744-1747
pubmed: 32673522
Environ Sci Pollut Res Int. 2009 Jun;16(4):439-42
pubmed: 19205767
J Infect Dis. 2020 Jun 29;222(2):214-222
pubmed: 32432672
N Engl J Med. 2020 Aug 6;383(6):592-594
pubmed: 32402157
Sci Rep. 2020 Feb 25;10(1):3411
pubmed: 32099043
Microorganisms. 2020 Jul 08;8(7):
pubmed: 32650492
PLoS One. 2014 Aug 01;9(8):e103560
pubmed: 25083787
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003
pubmed: 32165541
Virology. 2010 Nov 25;407(2):281-8
pubmed: 20850162
Am J Infect Control. 2020 Oct;48(10):1273-1275
pubmed: 32763344
Sci Rep. 2020 Jun 24;10(1):10285
pubmed: 32581288
Sci Rep. 2021 Jul 5;11(1):13804
pubmed: 34226623

Auteurs

Hiroshi Ueki (H)

Department of Virology, Institute of Medical Science, University of Tokyogrid.26999.3d, Tokyo, Japan.
Center for Global Viral Diseases, National Center for Global Health and Medicine, Tokyo, Japan.

Mutsumi Ito (M)

Department of Virology, Institute of Medical Science, University of Tokyogrid.26999.3d, Tokyo, Japan.

Yuri Furusawa (Y)

Department of Virology, Institute of Medical Science, University of Tokyogrid.26999.3d, Tokyo, Japan.
Laboratory of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.

Seiya Yamayoshi (S)

Department of Virology, Institute of Medical Science, University of Tokyogrid.26999.3d, Tokyo, Japan.
Center for Global Viral Diseases, National Center for Global Health and Medicine, Tokyo, Japan.

Shin-Ichiro Inoue (SI)

Advanced ICT Research Institute, National Institute of Information and Communications Technology (NICT), Kobe, Japan.

Yoshihiro Kawaoka (Y)

Department of Virology, Institute of Medical Science, University of Tokyogrid.26999.3d, Tokyo, Japan.
Center for Global Viral Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyogrid.26999.3d, Tokyo, Japan.
Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH